Repligen officer proposes sale of 12,946 shares
The notice also reports three prior common-stock sales by Olivier Loeillot, dated August 20, September 4 and September 21, 2026.
Rhea-AI Filing Summary
Repligen Corp. is the issuer named in a notice listing 12,946 common shares for sale for officer and director Olivier Loeillot's account, with an aggregate market value of $2,459,740.00. The proposed sale is dated September 24, 2026, through Fidelity Brokerage Services LLC on NASDAQ. The notice also lists 12,946 shares acquired from the issuer through a stock option exercise for cash on September 24, 2026, and three prior sales: 5,426 shares on August 20, 3,035 on September 4, and 5,426 on September 21, 2026.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Rule 144 regulatory
Stock Option Exercise financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.